Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 148

1.

Similar changes in cognitions following cognitive-behavioral therapy or escitalopram for major depressive disorder: Implications for mechanisms of change.

Farabaugh A, Fisher L, Nyer M, Holt D, Cohen M, Baer L, Shapero BG, Huz I, Cardoos A, Fava M, Alpert JE.

Ann Clin Psychiatry. 2015 May;27(2):118-25.

PMID:
25954938
2.

College students with depressive symptoms with and without fatigue: Differences in functioning, suicidality, anxiety, and depressive severity.

Nyer M, Mischoulon D, Alpert JE, Holt DJ, Brill CD, Yeung A, Pedrelli P, Baer L, Dording C, Huz I, Fisher L, Fava M, Farabaugh A.

Ann Clin Psychiatry. 2015 May;27(2):100-7.

PMID:
25954936
3.

Reliability and validity of the Symptoms of Depression Questionnaire (SDQ).

Pedrelli P, Blais MA, Alpert JE, Shelton RC, Walker RS, Fava M.

CNS Spectr. 2014 Dec;19(6):535-46. doi: 10.1017/S1092852914000406. Epub 2014 Oct 2.

PMID:
25275853
4.

Conditional probability of response or nonresponse of placebo compared with antidepressants or St John's Wort in major depressive disorder.

Sarris J, Nierenberg AA, Schweitzer I, Alpert JE, Rosenbaum JF, Iovieno N, Covino J, Fava M, Mischoulon D.

J Clin Psychopharmacol. 2013 Dec;33(6):827-30. doi: 10.1097/JCP.0b013e31829cc3af. No abstract available.

PMID:
24091858
5.

Interprofessional differences in disposition decisions: results from a standardized web-based patient assessment.

Gorrindo T, Goldfarb E, Chevalier L, Hoeppner BB, Birnbaum RJ, Meller B, Alpert JE, Herman J, Weiss AP.

Psychiatr Serv. 2013 Aug 1;64(8):808-11. doi: 10.1176/appi.ps.201200461.

PMID:
23903607
6.

How to get help with starting your research project: ADMSEP task force on research and scholarship.

Balon R, Alpert JE, Cluver JS, Lewis C; ADMSEP Task Force on Research and Scholarship.

Acad Psychiatry. 2013 Jul 1;37(4):221-2. doi: 10.1176/appi.ap.12070133. No abstract available.

PMID:
23820904
7.

Increased GsĪ± within blood cell membrane lipid microdomains in some depressive disorders: an exploratory study.

Mooney JJ, Samson JA, McHale NL, Pappalarado KM, Alpert JE, Schildkraut JJ.

J Psychiatr Res. 2013 Jun;47(6):706-11. doi: 10.1016/j.jpsychires.2013.02.005. Epub 2013 Mar 13.

8.

L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials.

Papakostas GI, Shelton RC, Zajecka JM, Etemad B, Rickels K, Clain A, Baer L, Dalton ED, Sacco GR, Schoenfeld D, Pencina M, Meisner A, Bottiglieri T, Nelson E, Mischoulon D, Alpert JE, Barbee JG, Zisook S, Fava M.

Am J Psychiatry. 2012 Dec;169(12):1267-74. doi: 10.1176/appi.ajp.2012.11071114.

PMID:
23212058
9.

Prevalence of MTHFR C677T and MS A2756G polymorphisms in major depressive disorder, and their impact on response to fluoxetine treatment.

Mischoulon D, Lamon-Fava S, Selhub J, Katz J, Papakostas GI, Iosifescu DV, Yeung AS, Dording CM, Farabaugh AH, Clain AJ, Baer L, Alpert JE, Nierenberg AA, Fava M.

CNS Spectr. 2012 Jun;17(2):76-86. doi: 10.1017/S1092852912000430.

10.

Bioavailability of S-adenosyl methionine and impact on response in a randomized, double-blind, placebo-controlled trial in major depressive disorder.

Mischoulon D, Alpert JE, Arning E, Bottiglieri T, Fava M, Papakostas GI.

J Clin Psychiatry. 2012 Jun;73(6):843-8. doi: 10.4088/JCP.11m07139. Epub 2012 May 15.

11.

Effects of S-adenosylmethionine augmentation of serotonin-reuptake inhibitor antidepressants on cognitive symptoms of major depressive disorder.

Levkovitz Y, Alpert JE, Brintz CE, Mischoulon D, Papakostas GI.

J Affect Disord. 2012 Feb;136(3):1174-8. doi: 10.1016/j.jad.2011.04.059. Epub 2011 Sep 10.

PMID:
21911258
12.

Effects of S-adenosylmethionine augmentation of serotonin-reuptake inhibitor antidepressants on cognitive symptoms of major depressive disorder.

Levkovitz Y, Alpert JE, Brintz CE, Mischoulon D, Papakostas GI.

Eur Psychiatry. 2012 Oct;27(7):518-21. doi: 10.1016/j.eurpsy.2011.03.006. Epub 2011 Jun 12.

PMID:
21665441
13.

Children of depressed mothers 1 year after remission of maternal depression: findings from the STAR*D-Child study.

Wickramaratne P, Gameroff MJ, Pilowsky DJ, Hughes CW, Garber J, Malloy E, King C, Cerda G, Sood AB, Alpert JE, Trivedi MH, Fava M, Rush AJ, Wisniewski S, Weissman MM.

Am J Psychiatry. 2011 Jun;168(6):593-602. doi: 10.1176/appi.ajp.2010.10010032. Epub 2011 Mar 15.

14.

SAMe and sexual functioning.

Dording CM, Mischoulon D, Shyu I, Alpert JE, Papakostas GI.

Eur Psychiatry. 2012 Aug;27(6):451-4. doi: 10.1016/j.eurpsy.2011.01.003. Epub 2011 Mar 12.

PMID:
21398094
15.

An approach to the psychopharmacologic care of patients: antidepressants, antipsychotics, anxiolytics, mood stabilizers, and natural remedies.

Huffman JC, Alpert JE.

Med Clin North Am. 2010 Nov;94(6):1141-60, x. doi: 10.1016/j.mcna.2010.08.009. Review.

PMID:
20951275
16.

S-adenosyl methionine (SAMe) augmentation of serotonin reuptake inhibitors for antidepressant nonresponders with major depressive disorder: a double-blind, randomized clinical trial.

Papakostas GI, Mischoulon D, Shyu I, Alpert JE, Fava M.

Am J Psychiatry. 2010 Aug;167(8):942-8. doi: 10.1176/appi.ajp.2009.09081198. Epub 2010 Jul 1.

PMID:
20595412
17.

Cognitive-behavioral therapy for patients with Parkinson's disease and comorbid major depressive disorder.

Farabaugh A, Locascio JJ, Yap L, Growdon J, Fava M, Crawford C, Matthews J, McCutchen J, Buchin J, Pava J, Alpert JE.

Psychosomatics. 2010 Mar-Apr;51(2):124-9. doi: 10.1176/appi.psy.51.2.124.

PMID:
20332287
18.

Psychiatric OSCE performance of students with and without a previous core psychiatry clerkship.

Goisman RM, Levin RM, Krupat E, Pelletier SR, Alpert JE.

Acad Psychiatry. 2010 Mar-Apr;34(2):141-4. doi: 10.1176/appi.ap.34.2.141.

PMID:
20224028
19.

Adverse endocrine and metabolic effects of psychotropic drugs: selective clinical review.

Bhuvaneswar CG, Baldessarini RJ, Harsh VL, Alpert JE.

CNS Drugs. 2009 Dec;23(12):1003-21. doi: 10.2165/11530020-000000000-00000. Review.

PMID:
19958039
20.

Factors associated with concomitant psychotropic drug use in the treatment of major depression: a STAR*D Report.

Shelton RC, Hollon SD, Wisniewski SR, Alpert JE, Balasubramani GK, Friedman ES, Rush AJ, Trivedi MH, Preskorn SH.

CNS Spectr. 2009 Sep;14(9):487-98.

PMID:
19890231
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk